Sandeep Singh

Basic and preclinical research on tumour microenvironment and non-genetic heterogeneity in cancer with integrative approach. Professor @FollowDbtNibmg

[BRIC - National Institute of Biomedical Genomics @FollowDbtNibmg]

Congratulations to the BRIC-NIBMG scientists recognized among the Top 5% Scientists Globally by SciRank Global!

This recognition reflects their outstanding research productivity and impact, placing them among the world's leading researchers. 🌍🔬
@DBTIndia @BricDbt @DrJitendraSingh @rajesh_gokhale @DrSagarSengupta @MaitraArindam @nkbhumgen @NImmunology @unescorcb
#NIBMG #BRIC #SciRank #TopScientists #ResearchExcellence #Genomics

[BRIC - National Institute of Biomedical Genomics @FollowDbtNibmg]

📢 BRIC-NIBMG is recruiting Assistant Professors!

We invite applications from eligible outstanding researchers in Cancer Biology, Host–Pathogen Interaction, Complex Disorders, Statistical Genomics, Neurogenomics, and related areas of biomedical genomics.
Selected faculty members will lead independent laboratories, mentor doctoral students, and contribute to BRIC-NIBMG’s growing research ecosystem.

🔗 Apply: https://t.co/piTah8iiXb
📄 Details: https://t.co/QA9HLpLLQe
@DBTIndia @BricDbt @rajesh_gokhale @DrJitendraSingh @DrSagarSengupta
#FacultyRecruitment #Genomics #BiomedicalResearch

[BRIC - National Institute of Biomedical Genomics @FollowDbtNibmg]

We are pleased to share that Ms. Subhashree Jena (PI: Prof. Sandeep Singh) received the First Runner-Up Award in the Basic Science Poster Competition at the 6th International Conference of the Global Cancer Consortium 2026 and the 15th East Zonal Oncology Symposium with IASO.

Her work highlighted the potential for reversing oral tumor grade from high to low, offering promising insights into differentiation therapy as a strategy to combat oral cancer.

Heartiest congratulations to Subhashree! 👏✨

@DBTIndia @BricDbt @DrJitendraSingh @rajesh_gokhale @DrSagarSengupta @StemCan
#bricnibmg #cancerresearch #oralcancer #translationalresearch #differentiationtherapy #ResearchExcellence #AwardAnnouncement

[Sandeep Singh @StemCan]

@AdhesionLab @BiophysJ @J_Cell_Sci Many congratulations and well deserved

[BRIC - National Institute of Biomedical Genomics @FollowDbtNibmg]

PhD Admissions Open | Dec 2025 🎓
Join NIBMG, India’s premier institute for Biomedical Genomics research.
We offer world-class training, cutting-edge facilities, and the opportunity to work on impactful projects in:
🔬Biomedical Genomics and the functional implications in the context of:
A. Cancer
B. Infectious disease
C. Chronic disease

💻Computational Biology and Statistical Genomics

📅Admissions open December 2025.

Be part of the next generation of researchers shaping the future of medicine.
#BRIC_NIBMG #PhDAdmissions #BiomedicalGenomics

@DBTIndia @BricDbt @DrJitendraSingh @rajesh_gokhale @DrSagarSengupta

[Sandeep Singh @StemCan]

@Aiims1742 @CD_AACR @triparnasen @MAF_Dawson Insightful. Thanks for sharing

[Sandeep Singh @StemCan]

Great to find our work got attention. Thanks @NatureInd for its wider spread. This work published in @JournalofExper1 has highlighted the tumor stromal interaction as possible prognostic and therapeutic target in oral cancer. @ANI @ncsmgoi

[BRIC - National Institute of Biomedical Genomics @FollowDbtNibmg]

Happy to share our recent feature in Nature India!
In the research, Prof. Sandeep Singh explores how stromal-Tie2 signaling drives oral cancer cell reprogramming, revealing new therapeutic angles.
Read: https://t.co/8VTfv8bw0z
#BRIC_NIBMG #OralCancer #CancerResearch

[Sandeep Singh @StemCan]

Read the Hindi version and thoroughly enjoyed. Kudos to the team for great efforts.

[BRIC - National Institute of Biomedical Genomics @FollowDbtNibmg]

Our newsletter IMPRINT Vol III, Issue III is out now!📰
Catch up on 6 months of science, outreach & creativity at @FollowDbtNibmg—now in English & Hindi!
From research highlights to student art, it’s all inside
Read: https://t.co/cUN27ihaMS
#BRIC_NIBMG #ScienceNewsletter #IMPRINT

[BRIC - National Institute of Biomedical Genomics @FollowDbtNibmg]

@FollowDbtNibmg offers access to high-end Genomics, Data Center, Zebrafish, Human Microbiome, BFDU, Proteomics, & Imaging facilities under @DBTIndia 's SAHAJ scheme.
Open to academia and industry
Charges:🔗https://t.co/dBp2NHgYvW
@DrJitendraSingh @DrSagarSengupta @rajesh_gokhale

[Department of Biotechnology @DBTIndia]

#India is charting a new course in healthcare with #BioE3policy- advancing precision therapeutics through novel gene therapies that are targeted and catered to the individual's profile.
Tailored treatments are turning real for India, as #precisiontherapeutics make headway with #BioE3.

@DrJitendraSingh @rajesh_gokhale

[Ashoka Global Research Alliances @GlobalAshoka]

📢 Indian scientists abroad - 🇮🇳 is calling!
Apply for prestigious @ANRFIndia Ramanujan Fellowship, choose @AshokaUniv as host.
Lead your own lab, do cutting-edge research & build a career.
Read More: https://t.co/S5jUalgOZe @PramathSinha @somakrc @AnuragAgrawalMD @kvijayraghavan

[Cancer Cell @Cancer_Cell]

A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies https://t.co/B7pgSxjaNg

[Department of Biotechnology @DBTIndia]

Join the open webinar tomorrow to know more about the #i3c BRIC-RCB PhD program in Biosciences

@DrJitendraSingh @rajesh_gokhale

[Sandeep Singh @StemCan]

@DBTIndia @DrJitendraSingh @rajesh_gokhale Very supportive move.

[Department of Biotechnology @DBTIndia]

#DBTIndia Update

The Govt of India has amended GFR 2017 for scientific Ministries including @DBTIndia, raising procurement limits for equipment and consumables.
Vice-Chancellors/Directors can approve Global Tenders up to ₹200 crore for justified research. These changes will speed up procurement and empower DBT institutions to boost innovation.

#ResearchSupport #ScienceForIndia #GFRUpdate

[Sandeep Singh @StemCan]

@DBTIndia @FollowDbtNibmg @DrJitendraSingh @rajesh_gokhale @BricDbt7510 Following up on this work to explore the ecological niches of Tie-activated CAFs in oral cancer and its role of patient prognostication, using #CosMx spatial technology platform. Thanks for supporting @DBTIndia @DrSagarSengupta

[Department of Biotechnology @DBTIndia]

BRIC @FollowDbtNibmg researchers explored the role of Tunica Interna Endothelial Cell Kinase (Tie2/TEK) signaling in transition and maintenance of myofibroblastic phenotype of #CAFs, providing wider applicability of Tie2-specific functions in tumor biology, along with its known role in endothelial cell-specific function.

🖇️Link to read: https://t.co/WZmIUkGPwn

@DrJitendraSingh @rajesh_gokhale @BricDbt7510

[Cancer Cell @Cancer_Cell]

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics https://t.co/J6CXdt2Jg0

[Department of Biotechnology @DBTIndia]

In a landmark initiative with far reaching futuristic implications, the Union Cabinet headed by the Hon’ble Prime Minister Shri Narendra Modi approved the BioE3 (Biotechnology for Economy, Employment and Environment) Policy of the Department of Biotechnology #DBT to foster high-performance biomanufacturing for a clean, green, prosperous, and self-reliant Bharat.

In a world facing pressing problems, the answers lie not just in what nature gives us but in how we reimagine biology itself. The future lies in transforming today’s consumptive manufacturing paradigm to the one based on regenerative principles. Today, marks an important step wherein @ICGEBNewDelhi in collaboration with the @DBTIndia, has established the country’s first state-of-the-art #Biofoundry at its campus. This pioneering initiative marks a significant milestone in advancing Synthetic Biology and Biotechnology Research in India.

@DrJitendraSingh
@rajesh_gokhale
@dralkasharma25
@ICGEB @ICGEBNewDelhi

[Sandeep Singh @StemCan]

Many thanks to @FollowDbtNibmg and @DBTIndia for supporting the work. Special mention @MaitraArindam @mkjolly15 and all other collaborators for their effort in shaping the work. #Collaboration #CancerResearch

[BRIC - National Institute of Biomedical Genomics @FollowDbtNibmg]

Prof. Sandeep Singh’s lab has discovered stromal CAFs with endothelial-like state, reprogram oral cancer cells to an embryonic-like state—driving stemness and poor prognosis in patients. 🧬🧫
Published in Journal of Experimental & Clinical Cancer Research: https://t.co/Fz3Tic4xk6